Both Fish Oil and Olive Oil Lowered Plasma Fibrinogen in Women with High Baseline Fibrinogen Levels

Summary This double-blind, cross-over study with olive oil as placebo, examined the effect of a daily dosage of 6 g fish oil on cardiovascular risk markers of 20 healthy young volunteers (10 men, 10 women). Serum lipids and lipoproteins, and plasma coagulation and fibrinolytic enzymes, including fibrinogen concentrations and plasminogen activator inhibitor-1 (PAI-1) activity were measured at baseline and after 6-week supplementation of either fish or olive oil. The results showed that fish oil had an independent lowering effect on triglycerides and coagulation factors Vc and VIIc. Both fish and olive oil significantly raised PAI-1 levels and lowered plasma factor Xc and fibrinogen levels in the women, who had higher initial levels than the men. Mean fibrinogen levels of the women were lowered from 3.23 ± 0.98 to 2.64 ± 0.55 g/1 and from 3.19 ± 0.72 to 2.66 ± 0.49 g/1 by fish and olive oil respectively. This study raises the question whether a particular fatty acid or group of fatty acids, or another constituent of the oil such as vitamin E may be responsible for the fibrinogen lowering effect.

[1]  D. Raccah,et al.  Plasminogen Activator Inhibitor Activity in Various Types of Endogenous Hypertriglyceridemia , 1993 .

[2]  L. Iacoviello,et al.  Modulation of fibrinolytic response to venous occlusion in humans by a combination of low-dose aspirin and n-3 polyunsaturated fatty acids. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[3]  E. Schmidt,et al.  Long-term supplementation with n-3 fatty acids, I: Effect on blood lipids, haemostasis and blood pressure. , 1992, Scandinavian journal of clinical and laboratory investigation.

[4]  E. Ernst Oral contraceptives, fibrinogen and cardiovascular risk. , 1992, Atherosclerosis.

[5]  C. Kluft,et al.  Insulin resistance and changes in haemostatic variables , 1992 .

[6]  A. Folsom,et al.  Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. , 1991, Atherosclerosis.

[7]  D. Roberts,et al.  Fish and fish oil intake: effect on haematological variables related to cardiovascular disease. , 1991, Thrombosis research.

[8]  J. Fruchart,et al.  n-3 polyunsaturated fatty acids raise low-density lipoproteins, high-density lipoprotein 2, and plasminogen-activator inhibitor in healthy young men. , 1991, The American journal of clinical nutrition.

[9]  M. Nikkilä Influence of fish oil on blood lipids in coronary artery disease. , 1991, European journal of clinical nutrition.

[10]  T. Saldeen,et al.  The effects of fish oil on triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin E. , 1991, The Journal of nutrition.

[11]  H. Tunstall-Pedoe,et al.  Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. , 1991, Journal of clinical epidemiology.

[12]  D. Ubben,et al.  Fibrinogen as a major risk factor in cardiovascular disease. , 1990, Trends in pharmacological sciences.

[13]  J. DeLany,et al.  Effects of fish oil on serum lipids in men during a controlled feeding trial. , 1990, The American journal of clinical nutrition.

[14]  J. Yudkin,et al.  Effects of Fish Oil Supplements in NIDDM Subjects: Controlled Study , 1990, Diabetes Care.

[15]  G. Huster,et al.  The comparative effects of n-3 and n-6 polyunsaturated fatty acids on plasma fibrinogen levels: a controlled clinical trial in hypertriglyceridemic subjects. , 1990, Journal of the American College of Nutrition.

[16]  T. Bjerkedal,et al.  Fish-oil concentrate: effects on variables related to cardiovascular disease. , 1990, The American journal of clinical nutrition.

[17]  A. Donker,et al.  Dose-response effects of fish-oil supplementation in healthy volunteers. , 1990, The American journal of clinical nutrition.

[18]  T. Saldeen,et al.  Effects of a new fluid fish oil concentrate, ESKIMO‐3, on triglycerides, cholesterol, fibrinogen and blood pressure , 1990, Journal of internal medicine.

[19]  H. Huisman,et al.  Metabolic and haemostatic consequences of dietary fibre and N-3 fatty acids in black type 2 (NIDDM) diabetic subjects: a placebo controlled study. , 1990 .

[20]  C. Lox The effects of dietary marine fish oils (omega-3 fatty acids) on coagulation profiles in men. , 1990, General pharmacology.

[21]  G. Huster,et al.  Dietary supplementation with low-dose fish oils lowers fibrinogen levels: a randomized, double-blind controlled study. , 1989, Annals of internal medicine.

[22]  K. Radack,et al.  Effects of modest doses of omega-3 fatty acids on lipids and lipoproteins in hypertriglyceridemic subjects. A randomized controlled trial. , 1989, Archives of internal medicine.

[23]  J. Emeis,et al.  A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. , 1989, Blood.

[24]  M. V. van Dam-Mieras,et al.  Effect of a Moderate Fish Intake on Haemostatic Parameters in Healthy Males , 1989, Thrombosis and Haemostasis.

[25]  W. Harris,et al.  Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. , 1989, Journal of lipid research.

[26]  H. Arnesen,et al.  Influence of highly concentrated n-3 fatty acids on serum lipids and hemostatic variables in survivors of myocardial infarction receiving either oral anticoagulants or matching placebo. , 1989, Thrombosis research.

[27]  J. Fincham,et al.  Plasma low density lipoprotein composition in relation to atherosclerosis in nutritionally defined Vervet monkeys. , 1988, Atherosclerosis.

[28]  J. Mehta,et al.  Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake. , 1988, American heart journal.

[29]  R. Gans,et al.  Fish oil and plasma fibrinogen. , 1988, BMJ.

[30]  J. Rossouw,et al.  Action limits for serum total cholesterol. A statement for the medical profession by an ad hoc committee of the Heart Foundation of Southern Africa. , 1988, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[31]  S. Shumak,et al.  Davidson's Principles and practice of medicine , 1988, The Ulster Medical Journal.

[32]  L. Kuller,et al.  Physical activity, insulin sensitivity, and the lipoprotein profile in young adults: the Beaver County Study. , 1988, American journal of epidemiology.

[33]  R. D'Agostino,et al.  Fibrinogen and risk of cardiovascular disease. The Framingham Study. , 1987, JAMA.

[34]  T. Sanders,et al.  Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics. , 1986, Thrombosis research.

[35]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[36]  C. J. Jones,et al.  Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment. , 1986, British medical journal.

[37]  C. von Schacky,et al.  Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. , 1985, The Journal of clinical investigation.

[38]  V. Pollak,et al.  Enhancing effect of dietary supplementation with omega-3 fatty acids on plasma fibrinolysis in normal subjects. , 1985, Thrombosis research.

[39]  T. Terano,et al.  EICOSAPENTAENOIC ACID AND PLATELET FUNCTION IN JAPANESE , 1984 .

[40]  T. Hamazaki,et al.  Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. , 1983, Atherosclerosis.

[41]  J. Dyerberg,et al.  HÆMOSTATIC FUNCTION AND PLATELET POLYUNSATURATED FATTY ACIDS IN ESKIMOS , 1979, The Lancet.